2021-2025 Stool Diagnostic Testing Market: Europe, Latin America, Middle East, North America-A 73-Country Analysis

November 2021 | | ID: 2F1F66CC25E0EN
Venture Planning Group

Abstracts

This new 73-country survey from LeadingMarketResearch.com provides granular data and analysis not available from any other source.

The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the stool diagnostic testing market during the next five years. The report is available by section, and can be customized to specific information needs and budget.

To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In Vitro Diagnostics Database.

Highlights

• Supplier market shares in Europe, Latin America, Middle East, and North America
• Five-year test volume and sales forecasts
• Strategic profiles of market players and start-up firms developing innovative technologies and products
• Emerging technologies
• Review of molecular diagnostic analyzers
• Specific product and business opportunities for instrument and consumable suppliers

Geographic Regions and Countries

Europe

Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine

Latin America

Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela

Middle East

Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates

North America

Canada, Mexico, USA

Market Segmentation Analysis

Market shares of key suppliers of stool diagnostic tests in major geographic regions.

Five-year test volume and sales forecasts for major tests, including:

• Adenovirus
• Calprotectin
• Campylobacter
• Clostridium difficil GDH
• Clostridium Toxins A and B
• Colon-Specific Antigen
• E. Coli
• Elastase
• Enterohemorrhagic E. coli toxins
• Enterovirus
• Helicobacter Pylori
• Occult Blood
• Rotavirus
• Shigella

Competitive Assessments

• Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
• Companies developing and marketing stool diagnostic products.

Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contents

INTRODUCTION

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

WORLDWIDE OVERVIEW OF MAJOR TESTS, TECHNOLOGIES, AND INSTRUMENTATION

A. Major Stool Diagnostic Tests
  1. Adenovirus
  2. Calprotectin
  3. Campylobacter
  4. Clostridium difficil GDH
  5. Clostridium Toxins A and B
  6. Colon-Specific Antigen
  7. E. Coli
  8. Elastase
  9. Enterohemorrhagic E. coli toxins
  10. Enterovirus
  11. Helicobacter Pylori
  12. Occult Blood
  13. Rotavirus
  14. Shigella
B. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Others
Europe, LatAm, Middle East, North America: Supplier Shares and 73-Country Analysis
Albania, Argentina, Austria, Bahrain, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, El Salvador, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Haiti, Honduras, Hungary, Iceland, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Malta, Mexico, Moldova, Netherlands, Nicaragua, Norway, Oman, Panama, Paraguay, Peru, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela

COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Quest Diagnostics
Quidel
Roche
Scienion
Sequenom/LabCorp
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Wako Chemical